The Placebo Effect: Another Word for the Mind–Body Connection

The placebo effect is receiving long-overdue attention in medicine.

For decades, placebo has been used primarily as a control in clinical trials—a way to determine whether a medication works better than an inactive pill or simulated treatment. Over time, the word also became a form of dismissal:

It was only the placebo effect.

The treatment did not work any better than placebo.

This language creates a false divide: either a treatment produced a “real” biological effect, or the person imagined feeling better.

But the placebo effect is psychobiological. It reflects the measurable ways that expectation, prior experience, learning, relationship, and the meaning surrounding treatment can influence how the brain and body respond.

A placebo pill may be pharmacologically inactive. The experience of receiving it is not.

This does not mean that hope can cure every illness, that symptoms are imaginary, or that medical treatment is unnecessary. It means that treatment is never received in a vacuum. Every medication, procedure, and therapeutic encounter is experienced by a nervous system that is continually interpreting internal sensations in relation to the physical, psychological, and relational environment—as well as a person’s prior beliefs and expectations.

These factors are not separate from biology. They are part of the context through which symptoms and treatment are experienced. A recent review in The Lancet Psychiatry argues that placebo and nocebo effects should be understood as clinically relevant processes that occur alongside active treatment—not as irrelevant background noise.

Placebo Effect or Placebo Response?

A placebo is an inactive substance or simulated treatment used to determine whether an active treatment offers benefits beyond those associated with receiving care.

The broader placebo response includes everything that improves in a placebo group: the natural course of symptoms, regression to the mean, added attention and support, changes in self-care, and the placebo effect itself.

The placebo effect refers more specifically to changes shaped by expectation, learning, relationship, and the meaning surrounding treatment.

This distinction matters. Someone may enter a clinical trial when symptoms are unusually severe and improve as they naturally return closer to their typical level. Participating in a study may also bring more structure, attention, and consistent care.

Improvement in a placebo group therefore cannot automatically be attributed to belief or the mind–body connection. Placebo is not one mysterious force, but a collection of biological, psychological, relational, and contextual processes.

Expectation, Learning, and Relationship

Expectation is not simply positive thinking. It can be understood as the brain’s prediction about what is likely to happen based on prior experience, available information, and whether a treatment feels credible.

In open-versus-hidden treatment studies, the same active medication may have a stronger effect when someone knows it is being administered than when it is given without their awareness. The medication is unchanged; the context is different.

The nervous system also learns through repetition. A pill, treatment setting, procedure, or trusted clinician may become associated with relief—or discomfort. The body recognizes familiar patterns and prepares for what it has learned may come next.

The therapeutic relationship is part of this context. In a study of people with irritable bowel syndrome, researchers compared observation alone, sham acupuncture delivered with limited interaction, and the same sham procedure delivered within a warm, attentive therapeutic encounter. The most supportive condition included careful listening, empathy, and confident communication about the treatment process. Participants in this group reported the greatest improvement.

The procedure was the same. The encounter was not.

This does not mean empathy replaces effective treatment. It suggests that treatment may be experienced differently when people feel believed, understand the plan, and trust that their response will be taken seriously.

What Is Happening in the Brain?

There is no single placebo pathway. Placebo effects involve systems related to expectation, learning, attention, emotion, motivation, and the interpretation of sensory information.

Pain offers the clearest example. Pain intensity is not a direct readout of tissue damage. The brain combines sensory signals with memory, emotion, context, and predictions about danger or safety.

Expectations of relief can engage the body’s own opioid system and pathways involved in pain regulation. Research has also implicated networks involved in learning, reward, and motivation.

This does not mean thoughts override biology. It means that meaning, experience, and biology continually interact.

Feeling Better Is Not Always the Same as Treating Disease

Placebo effects are particularly relevant to symptoms such as pain, nausea, fatigue, anxiety, and breathlessness. That does not make these symptoms “just psychological.” Relief is a meaningful clinical outcome.

But symptom improvement does not always mean that an underlying disease process has changed.

In one asthma study, participants reported similar subjective improvement after receiving active albuterol, a placebo inhaler, or sham acupuncture. Only albuterol, however, produced a substantial objective improvement in lung function.

Both outcomes matter. We want people to feel better, and we need to know whether a treatment is changing the underlying condition.

The placebo effect should complement effective medical care, not replace it.

The Nocebo Effect

The same processes can also intensify discomfort.

The nocebo effect occurs when negative expectations, fear, previous experiences, or the way risks are communicated contribute to increased symptoms or side effects.

The symptoms are real. A nervous system anticipating danger may become more vigilant, pay closer attention to bodily sensations, and interpret ambiguous signals as signs that something is wrong.

This creates an important challenge for clinicians. Informed consent requires honesty, but framing matters.

There is a difference between saying:

“This medication causes terrible withdrawal.”

and:

“Some people experience withdrawal symptoms, particularly when the medication is reduced too quickly. We can lower that risk by tapering gradually and adjusting the pace based on your response.”

Both acknowledge risk. The second also provides context, agency, and a plan.

The goal is not to minimize potential harm. It is to communicate accurately without unnecessarily amplifying fear.

Realistic Hope

Hope is not a guarantee or pressure to think positively. It is the ability to hold uncertainty while remaining open to change:

There are reasons to believe this may help.

We will adjust the plan based on how you respond.

Hope cannot make an ineffective treatment work, and someone has not failed if they do not improve. But realistic hope can reduce helplessness and support active participation in care.

Applying This Knowledge

We do not need to prescribe inactive pills or exaggerate the benefits of treatment. The more useful lesson is that context already influences care.

We can strengthen treatment by building credible relationships, explaining why an intervention is being recommended, offering realistic hope, inviting patients into collaborative decisions, and communicating risks without catastrophizing.

These elements should be paired with sound medical care. The therapeutic relationship should strengthen effective treatment, not justify unsupported interventions.

Rethinking What Makes Treatment Work

A medication is never received in isolation. It arrives with an explanation of what it may do, memories of previous treatment, a relationship with the person recommending it, and hopes or fears about what comes next.

The active treatment matters. So does whether the person trusts the plan, understands what they are experiencing, and feels heard.

The placebo effect is not an alternative to real treatment. It is one component of how real treatment works.

Rather than dismissing improvement as “just placebo,” we might ask what helped: a greater sense of safety, feeling cared for, a less frightening explanation, or finally having a credible plan.

These do not replace the active ingredients of treatment. They are part of how good treatment works.

Reference

  1. Burke MJ, Sandra DA, Peciña M, et al. Harnessing placebo effects and mitigating nocebo effects: implications for clinical practice in psychiatry and medicine. The Lancet Psychiatry. 2026;13(5):413–425. doi:10.1016/S2215-0366(25)00340-2..

Next
Next

What Is Psychedelic Harm Reduction?